# Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

> **NCT02726750** · — · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 200 (estimated)

## Conditions studied

- Monoclonal Gammopathy of Undetermined Significance
- Smoldering Plasma Cell Myeloma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT02726750
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2015-12-14
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02726750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02726750, "Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02726750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*